RICHMOND, Va., December 19, 2017- Virginia Bio, the premier statewide non-profit association representing the life science industry in the Commonwealth of Virginia, has elected two new members to their Board of Directors for a term of three years. The election took place on December 14, 2017 at the Virginia Bio Annual Membership meeting in Richmond, Virginia. The new directors will begin their terms effective on January 1, 2018.
The newly elected directors are Jeff Pompeo, President and CEO of Caretaker Medical Corporation a Medical Device company located in Charlottesville VA that is commercializing an innovative Wireless Vital Signs and Continuous Blood Pressure Monitoring Platform; and Kyp Sirinakis, the Co-founder and Managing Partner of Epidarex Capital, a transatlantic venture capital firm which invests in early stage life science and health technology companies in under-ventured markets within the US and Europe.
“Having received the benefits of being a Virginia Bio member for many years, I’m now excited to be on the board to help shape priorities and initiatives. Jeff Gallagher and his team have done a tremendous job advancing the interests of Virginia Biotech in very real terms, and I’m honored to be in a position to assist,” said new board member Jeff Pompeo.
Kyp Sirinakis stated of the election, “I’m honored to join the Virginia Bio Board of Directors and look forward to contributing in the advancement of the organization priorities in the coming years. Access to capital is an important initiative for the state’s life science sector and I hope I can help Virginia Bio address this important issue through my role on the Board.”
Members also elected Carrie Roth, President and CEO of Virginia Bio+Tech Park in Richmond. to serve a second three-year term on the Board of Directors, along with Andrew Krouse, President and CEO of Cavion Pharmaceuticals, and William Stilley, CEO of ADial Pharmaceuticals, both of Charlottesville, to serve a third three-year term.
New Board Member Backgrounds:
Jeff Pompeo is a serial entrepreneur with deep experience leading large corporate organizations as well as innovative technology and Med-Tech start-ups. He has held executive level Engineering and Commercial leadership positions with publicly traded companies such as General Electric, AXA, and American Management Systems as well as with a diverse group of private consulting and technology firms.
Jeff got his first taste of entrepreneurship while serving as CIO of General Electric’s Industrial Automation unit, when he founded and lead a joint venture between GE and Cisco Systems focused on Industrial data networks. Having been smitten by the entrepreneurial bug, he left GE in 2000 to help launch a Telecom startup, raising $60M in venture capital and quickly growing to over 150 employees prior to exit. Jeff then went on to hold senior executive positions in numerous other Start-Up firms in the Telecom, Electronics Engineering, and Medical Device industries.
Currently, Jeff serves as President and CEO of Caretaker Medical Corp, a Medical Device company located in Charlottesville VA that is commercializing an innovative Wireless Vital Signs and Continuous Blood Pressure Monitoring Platform. Previous to starting Caretaker Medical in 2014, Jeff served as President & CEO of PocketSonics, a Medical Device start-up spun out of the University of Virginia’s Biomedical Engineering Labs. Under his leadership, the company developed an innovative Handheld Ultrasound platform for guiding vascular access procedures, which was acquired by Analogic Corporation (nasdaq:ALOG) in 2013.
Jeff earned a degree in Computer Information Systems from James Madison University and an MBA from Virginia Tech. He lives in Charlottesville, VA with his wife Lisa and their 4 children. He serves on the board of directors of TSO3 Corporation (Tor:TSO3), and serves on the advisory board of James Madison University’s Center of Entrepreneurship.
Kyp Sirinakis has more than 25 years of experience in creating and growing companies both as an early-stage venture investor and a senior executive in various technology and life science companies. Based in Maryland, Kyp is the Co-founder and Managing Partner of Epidarex Capital, a transatlantic venture capital firm which invests in early stage life science and health technology companies in under-ventured markets within the US and Europe. Epidarex’s portfolio has a strong emphasis on starting and funding companies based on university intellectual property. Prior to launching Epidarex, she was part of the senior management team of MASA Life Science Ventures, an early stage life science venture fund. Kyp also was the Founder and Managing Director of WomenAngels.net LLC, a top tier fund investing in startup technology and healthcare companies in the Washington DC metro region. She was the CFO of Oncologix, a venture-backed, early-stage biotechnology company based in Gaithersburg which was subsequently sold to Antigenics, Inc. Kyp has extensive experience collaborating with numerous universities in the US and UK. In addition, she was previously the Director of a technology accelerator at George Mason University’s (GMU) Entrepreneurship Center and an Adjunct Professor teaching venture capital at GMU’s Executive MBA program. Kyp is a frequent speaker on early stage investing and venture capital.
Kyp serves on the Investment Advisory Committees for Virginia’s Center for Innovative Technology BioLife Fund, the Momentum Fund (University of Maryland System) and the Ivy Foundation at the University of Virginia. She is member of the Biotech Advisory Committee for the Sid Martin Biotechnology Institute in Florida and the Virginia Research Investment Fund’s External Industry Peer Review Committee. Kyp has held numerous directorships of start-up companies throughout her career and is currently on the Board of, Sirakoss Ltd, Nodthera Ltd. , IGEM Therapeutics Ltd. and Eternygen GmbH. She is a graduate of Boston College’s School of Management Honors Program.
You can view the complete list of Virginia Bio board members at http://www.vabio.org/?leadership.
About the Virginia Biotechnology Association
Virginia Bio is the premier statewide non-profit trade association for life sciences, promoting the considerable scientific and economic impact of the life sciences industry in the Commonwealth of Virginia. Virginia Bio is an advocate for innovation and entrepreneurship, and for the biopharmaceutical, and other health technology industries among federal, state and local policy-makers. Virginia Bio is the official state affiliate of the Biotechnology Industry Organization (BIO), AdvaMed and the Medical Device Manufacturers Association (MDMA) and also collaborates closely with the Pharmaceutical Research and Manufacturers of America (PhRMA). To learn more, visit www.vabio.org or Follow Virginia Bio on Twitter at @VABio.
Click here to download the original press release.